Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Trial Profile

Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Discontinued
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2017 Status changed from active, no longer recruiting to discontinued.
    • 23 Jul 2008 The expected completion date for this trial is now 1 Jan 2008.
    • 21 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top